HK Inno.N (195940.KQ) Stock Price

HK Inno.N Price

CLOSED
40,300.00
​
Market closed

Revenue has compounded at 17.9% per year over the past 7 years to 1.06 T KRW. Earnings per share have grown at 34.2% per year over the last 6 years. HK Inno.N's net margin stands at 7.1%, up from 3.2% several years earlier. HK Inno.N currently offers a dividend yield of about 0.87%. The payout ratio is around 13% of earnings. The dividend has grown at 2.3% per year over the past 4 years. Analysts set a median price target of 66,300.00 KRW, implying 64.5% above the current price. Of 17 analysts, 16 rate the stock a buy — an overall Buy consensus.

HK Inno.N stock price

Access this data via the Eulerpool API

HK Inno.N business model & stock analysis

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do and currently employs 1,710 full-time employees. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Frequently asked questions about HK Inno.N

Analysts currently set an average price target of 65,960.00 KRW for the HK Inno.N stock (median: 66,300.00 KRW), implying +63.7 % versus the latest price. The consensus is based on 17 analyst ratings.

17 analysts currently rate the HK Inno.N stock: 16 recommend buying, 1 holding and 0 selling. For 2026, analysts expect HK Inno.N to generate revenue of 1.10 T KRW and earnings per share of 3,228.33 KRW.

Converted at the current exchange rate, the HK Inno.N share trades at 26.80 EUR (40,300.00 KRW).

The expected revenue of HK Inno.N is 1.10 T KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of HK Inno.N is 91.46 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of HK Inno.N is currently 12.48. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the HK Inno.N stock.

The price-to-sales ratio (P/S) of HK Inno.N is currently 1.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the HK Inno.N stock.

The Eulerpool Quality Score for HK Inno.N is 5/10.

The ISIN of HK Inno.N is KR7195940002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of HK Inno.N is 195940.KQ. The ticker symbol is used to trade HK Inno.N shares on the stock exchange.

Fair ValueTerminal
37,076.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
621.73 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website inno-n.com
Country
South Korea
Currency
KRW
Initial public offering
Aug 9, 2021
ISIN
KR7195940002
Cusip
Y166C3102
Market capitalization
1.14 T KRWMega Cap
52-Week Range
PEG
1.24
P/E ratio
P/Ee 2026
12.48
P/Ee 2027
10.46
P/Ee 2028
8.84
P/S
P/Se
1.04
EV/EBIT
11.46
P/B Ratio
0.86
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.14 %
Dividend
Dividend yield
0.87 %
Est. Dividend Yield
1.02 %
Payout Ratio
13.10 %
Dividend growth Ø5Y
5.08 %
Dividend payments per year
1
Dividend paid since
1 year
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
22.00 %
Last updated Oct 11, 2026, 2:33 AM

HK Inno.N Peer Group

HK Inno.N FIGI

195940:KS · BBG00865GWN1195940:KQ · BBG011MRXY01

All fundamentals and in-depth analysis of HK Inno.N

Our stock analysis for HK Inno.N stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HK Inno.N. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.